全文获取类型
收费全文 | 12828篇 |
免费 | 1171篇 |
国内免费 | 350篇 |
专业分类
耳鼻咽喉 | 145篇 |
儿科学 | 105篇 |
妇产科学 | 77篇 |
基础医学 | 1056篇 |
口腔科学 | 691篇 |
临床医学 | 1430篇 |
内科学 | 980篇 |
皮肤病学 | 581篇 |
神经病学 | 313篇 |
特种医学 | 715篇 |
外国民族医学 | 1篇 |
外科学 | 3428篇 |
综合类 | 1826篇 |
一般理论 | 3篇 |
预防医学 | 648篇 |
眼科学 | 881篇 |
药学 | 795篇 |
31篇 | |
中国医学 | 447篇 |
肿瘤学 | 196篇 |
出版年
2024年 | 75篇 |
2023年 | 430篇 |
2022年 | 536篇 |
2021年 | 631篇 |
2020年 | 676篇 |
2019年 | 540篇 |
2018年 | 492篇 |
2017年 | 531篇 |
2016年 | 553篇 |
2015年 | 492篇 |
2014年 | 814篇 |
2013年 | 978篇 |
2012年 | 664篇 |
2011年 | 724篇 |
2010年 | 673篇 |
2009年 | 545篇 |
2008年 | 516篇 |
2007年 | 550篇 |
2006年 | 457篇 |
2005年 | 451篇 |
2004年 | 410篇 |
2003年 | 361篇 |
2002年 | 306篇 |
2001年 | 292篇 |
2000年 | 207篇 |
1999年 | 186篇 |
1998年 | 167篇 |
1997年 | 163篇 |
1996年 | 103篇 |
1995年 | 104篇 |
1994年 | 88篇 |
1993年 | 64篇 |
1992年 | 68篇 |
1991年 | 59篇 |
1990年 | 45篇 |
1989年 | 31篇 |
1988年 | 42篇 |
1987年 | 30篇 |
1986年 | 31篇 |
1985年 | 48篇 |
1984年 | 42篇 |
1983年 | 22篇 |
1982年 | 28篇 |
1981年 | 28篇 |
1980年 | 24篇 |
1979年 | 17篇 |
1978年 | 12篇 |
1977年 | 8篇 |
1976年 | 15篇 |
1974年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
4.
5.
目的探讨分析对急性结石性胆囊炎患者采用腹腔镜胆囊切除术进行治疗的临床效果,以及对患者的胃肠功能和C反应蛋白所造成的影响。方法本次研究对象乃是我院肝胆外科于2017年4月-2019年4月期间收治的急性结石性胆囊炎患者62例,按照患者就诊的先后顺序对其进行平均分组,比较两组患者的术后肠鸣音恢复时间、肛门排气时间、排便时间、C反应蛋白水平以及并发症发生率。结果腹腔镜手术组患者的术后肠鸣音恢复时间(13.6±3.5)小时、肛门排气时间(16.5±2.7)小时以及排便时间(25.7±3.3)小时,均明显少于开腹式手术组患者(P<0.05);腹腔镜手术组患者的术后并发症发生率(6.45%)明显低于开腹式手术组患者(25.80%)(P<0.05);腹腔镜手术组患者的C反应蛋白水平为(10.4±2.5)mg/L,少于开腹式手术组患者(P<0.05)。结论根据本次研究的结果可以确认,对急性结石性胆囊炎患者采用腹腔镜胆囊切除术进行治疗能够取得更好的效果,可以促使患者的胃肠功能在术后更快的恢复,提高患者的C反应蛋白,从而有效避免患者出现并发症。 相似文献
6.
Erik de Bakker Mirthe A. M. van der Putten Martijn W. Heymans Sander W. Spiekstra Taco Waaijman Liselotte Butzelaar Vera L. Negenborn Vivian K. Beekman Erman O. Akpinar Thomas Rustemeyer Frank B. Niessen Susan Gibbs 《Experimental dermatology》2021,30(1):169-178
Unpredictable hypertrophic scarring (HS) occurs after approximately 35% of all surgical procedures and causes significant physical and psychological complaints. Parallel to the need to understanding the mechanisms underlying HS formation, a prognostic tool is needed. The objective was to determine whether (systemic) immunological differences exist between patients who develop HS and those who develop normotrophic scars (NS) and to assess whether those differences can be used to identify patients prone to developing HS. A prospective cohort study with NS and HS groups in which (a) cytokine release by peripheral blood mononuclear cells (PBMC) and (b) the irritation threshold (IT) after an irritant (sodium lauryl sulphate) patch test was evaluated. Univariate regression analysis of PBMC cytokine secretion showed that low MCP‐1, IL‐8, IL‐18 and IL‐23 levels have a strong correlation with HS (P < .010‐0.004; AUC = 0.790‐0.883). Notably, combinations of two or three cytokines (TNF‐a, MCP‐1 and IL‐23; AUC: 0.942, Nagelkerke R2: 0.727) showed an improved AUC indicating a better correlation with HS than single cytokine analysis. These combination models produce good prognostic results over a broad probability range (sensitivity: 93.8%, specificity 86.7%, accuracy 90,25% between probability 0.3 and 0.7). Furthermore, the HS group had a lower IT than the NS group and an accuracy of 68%. In conclusion, very fundamental immunological differences exist between individuals who develop HS and those who do not, whereas the cytokine assay forms the basis of a predictive prognostic test for HS formation, the less invasive, easily performed irritant skin patch test is more accessible for daily practice. 相似文献
7.
糖尿病足溃疡(DFUs)是糖尿病严重的并发症之一,发病率和截肢率高,目前具体发病机制仍未完全明确。相关研究表明,炎症、感染和营养障碍等多种因素共同影响DFUs的转归及预后。抑制相关炎症通路和细胞因子表达,可促使坏死组织脱落促进愈合。此外,细胞因子信号传导抑制因子家族蛋白(SOCS)可通过激活蛋白酪氨酸激酶(JAK)/信号转导和转录活化因子(STAT)信号通路参与细胞因子信号转导,参与DFUs创面炎症反应以及愈合过程。近年来,大量研究发现具有“去腐生新”功效的单味中药及其活性成分、中药复方对DFUs具有很好的疗效,研究中药治疗DFUs的具体机制已成为近些年来研究的热点之一。文章查阅近年文献,就SOCS通路与DFUs的关系及中医药治疗DFUs作用机制进行综述。 相似文献
8.
9.
10.
《Journal of endodontics》2019,45(10):1228-1236
IntroductionThe balance between the host proinflammatory immune response and the counteracting anti-inflammatory and reparative responses supposedly determine the outcome of periapical lesions. In this scenario, the vasoactive intestinal peptide (VIP) may exert a protective role because of its prominent immunoregulatory capacity. In this study, we investigated (in a cause-and-effect manner) the potential involvement of VIP in the development of human and experimental periapical lesions.MethodsPeriapical granulomas (n = 124) and control samples (n = 48) were comparatively assessed for VIP and multiple immunologic/activity marker expression through real-time polymerase chain reaction. Experimental periapical lesions (C57Bl/6 wild-type mice) were evaluated regarding endogenous VIP expression correlation with lesion development and the effect of recombinant VIP therapy in lesion outcome. CCR4KO and IL4KO strains and anti-glucocorticoid-induced TNFR-related protein inhibition were used to test the involvement of Treg and Th2 cells in VIP-mediated effects.ResultsVIP expression was more prevalent in periapical granulomas than in controls, presenting a positive association with immunoregulatory factors and an inverse association/correlation with proinflammatory mediators and the receptor activator of nuclear factor kappa B ligand/osteoprotegerin ratio. Endogenous VIP expression up-regulation was temporally associated with lesion immunoregulation and a decline of bone loss. VIP therapy in mice prompted the arrest of lesion development, being associated with an anti-inflammatory and proreparative response that limits the proinflammatory, Th1, Th17, and osteoclastogenic response in the periapex. The VIP protective effect was dependent of Treg migration and activity and independent of interleukin 4.ConclusionsOur results show that VIP overexpression in human and experimental periapical lesions is associated with lesion inactivity and that VIP therapy results in the attenuation of experimental lesion progression associated with the immunosuppressive response involving Treg cells. 相似文献